A detailed history of First Horizon Advisors, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 259,166 shares of JNJ stock, worth $39.7 Million. This represents 1.17% of its overall portfolio holdings.

Number of Shares
259,166
Previous 248,844 4.15%
Holding current value
$39.7 Million
Previous $36.4 Million 15.48%
% of portfolio
1.17%
Previous 1.11%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$145.48 - $167.38 $1.5 Million - $1.73 Million
10,322 Added 4.15%
259,166 $42 Million
Q2 2024

Jul 19, 2024

BUY
$144.38 - $157.78 $622,566 - $680,347
4,312 Added 1.76%
248,844 $36.4 Million
Q1 2024

Apr 26, 2024

BUY
$155.22 - $162.74 $1.08 Million - $1.13 Million
6,933 Added 2.92%
244,532 $38.7 Million
Q4 2023

Feb 06, 2024

SELL
$145.6 - $158.88 $217,963 - $237,843
-1,497 Reduced 0.63%
237,599 $37.2 Million
Q3 2023

Oct 27, 2023

SELL
$155.75 - $174.48 $381,899 - $427,824
-2,452 Reduced 1.02%
239,096 $37.2 Million
Q2 2023

Aug 03, 2023

BUY
$154.35 - $166.11 $224,887 - $242,022
1,457 Added 0.61%
241,548 $40 Million
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $1.33 Million - $1.58 Million
8,781 Added 3.8%
240,091 $37.2 Million
Q4 2022

Feb 10, 2023

SELL
$160.2 - $179.79 $9,772 - $10,967
-61 Reduced 0.03%
231,310 $40.9 Million
Q3 2022

Nov 09, 2022

SELL
$161.33 - $179.52 $621,443 - $691,511
-3,852 Reduced 1.64%
231,371 $37.8 Million
Q2 2022

Aug 02, 2022

BUY
$168.19 - $186.01 $13.9 Million - $15.4 Million
82,890 Added 54.41%
235,223 $41.8 Million
Q1 2022

May 10, 2022

SELL
$158.14 - $179.59 $9.81 Million - $11.1 Million
-62,050 Reduced 28.94%
152,333 $27 Million
Q4 2021

Feb 09, 2022

BUY
$155.93 - $173.01 $1.17 Million - $1.3 Million
7,526 Added 3.64%
214,383 $36.7 Million
Q3 2021

Nov 15, 2021

SELL
$161.5 - $179.47 $1.25 Million - $1.39 Million
-7,746 Reduced 3.61%
206,857 $33.4 Million
Q3 2021

Nov 09, 2021

BUY
$161.5 - $179.47 $17.5 Million - $19.4 Million
108,165 Added 101.62%
214,603 $34.7 Million
Q2 2021

Aug 09, 2021

BUY
$159.48 - $171.07 $320,873 - $344,192
2,012 Added 1.93%
106,438 $17.5 Million
Q1 2021

May 11, 2021

BUY
$153.07 - $170.48 $390,328 - $434,724
2,550 Added 2.5%
104,426 $17.2 Million
Q4 2020

Feb 11, 2021

BUY
$137.11 - $157.38 $153,837 - $176,580
1,122 Added 1.11%
101,876 $16 Million
Q3 2020

Nov 12, 2020

SELL
$140.38 - $153.83 $307,712 - $337,195
-2,192 Reduced 2.13%
100,754 $15 Million
Q2 2020

Jul 31, 2020

BUY
$128.81 - $155.51 $259,036 - $312,730
2,011 Added 1.99%
102,946 $14.5 Million
Q1 2020

May 05, 2020

BUY
$111.14 - $153.99 $81,687 - $113,182
735 Added 0.73%
100,935 $13.2 Million
Q4 2019

Jan 07, 2020

BUY
$127.5 - $146.44 $408,255 - $468,900
3,202 Added 3.3%
100,200 $14.6 Million
Q3 2019

Oct 23, 2019

SELL
$126.95 - $142.14 $907,692 - $1.02 Million
-7,150 Reduced 6.87%
96,998 $12.5 Million
Q2 2019

Aug 05, 2019

BUY
$131.15 - $144.24 $519,222 - $571,046
3,959 Added 3.95%
104,148 $0
Q1 2019

Apr 26, 2019

BUY
$125.72 - $139.79 $629,605 - $700,068
5,008 Added 5.26%
100,189 $0
Q4 2018

Feb 11, 2019

BUY
$122.84 - $147.84 $213,741 - $257,241
1,740 Added 1.86%
95,181 $12.3 Million
Q3 2018

Nov 05, 2018

BUY
$121.58 - $142.88 $9.32 Million - $11 Million
76,663 Added 456.93%
93,441 $0
Q3 2018

Nov 05, 2018

SELL
$121.58 - $142.88 $9.23 Million - $10.9 Million
-75,944 Reduced 81.91%
16,778 $0
Q2 2018

Aug 07, 2018

BUY
$119.4 - $131.76 $3.78 Million - $4.17 Million
31,657 Added 51.84%
92,722 $0
Q1 2018

May 02, 2018

BUY
$125.1 - $148.14 $322,632 - $382,053
2,579 Added 4.41%
61,065 $0
Q4 2017

Jan 25, 2018

BUY
$131.22 - $143.62 $421,084 - $460,876
3,209 Added 5.81%
58,486 $0
Q3 2017

Nov 09, 2017

BUY
$129.47 - $135.38 $290,271 - $303,521
2,242 Added 4.23%
55,277 $0
Q2 2017

Aug 14, 2017

BUY
N/A
53,035
53,035 $0

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $400B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.